US5458140A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
Assignee: Nitto Denko Corp
•
Filing: 1993-11-15
•
Granted: 1995-10-17
•
Expires: 2013-11-15
Abstract
Abstract A method of enhancing the permeability of the skin or mucosa to an analyte for diagnostic purposed is described utilizing ultrasound or ultrasound plus a chemical enhancer. If desired the ultrasound may be modulated by means of frequency modulation, amplitude modulation, phase modulation and/or combinations thereof. A frequency modulation from low to high develops a local pressure gradient directed out of the body, thus permitting analytes in the body to traverse the skin and be collected and measured outside the body. The concentration of an analyte in the body is preferably determined by enhancing the permeability of the skin or other biological membrane optionally with a chemical enhancer, applying ultrasound optionally at a modulated frequency, amplitude, phase, or combinations thereof that further induces a local pressure gradient out of the body, collecting the analyte, and utilizing the analyte collection data calculating the concentration of the analyte in the body.
Inventors
- 👤 Jonathan A. Eppstein
- 👤 Deborah A. Eppstein
- 👤 Joseph Kost
- 👤 Robert S. Langer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:55
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1468; A61B5/1486; A61B5/14507; A61B5/1451; A61B5/14514; A61B5/68; A61B5/6801; A61B5/6802; A61B5/681; A61K; A61K41/00; A61K41/0047; A61K49/00; A61K49/22; A61B18/00; A61B18/18; A61B18/20; A61B18/203; A61B17/00; A61B2017/00017; A61B2017/00137; A61B2017/00154; A61B2017/00172; A61B2017/00743; A61B2017/00747; A61B2017/00765; A61B2018/00315; A61B2018/00452; A61B2018/0047; A61B2562/00; A61B2562/02; A61B2562/0295; A61M; A61M37/00; A61M2037/0007; A61M37/0092
Claims Analysis
Total Claims: 28
Claim 1
Independent Claim
97 words
A method for non-invasively monitoring the concentration of an analyte in an individual's body comprising the steps of: (a) enhancing the permeability of a selected area of the individual's body surface to the analyte by means of applying ultrasound to said selected area for a time and at an intensity and a frequency effective to draw the analyte out of the body, wherein said ultrasound is modulated by means of a member selected from the group consisting of frequency modulation, amplitude modulation, phase modulation and combinations thereof; (b) collecting the analyte; and (c) quantitating the analyte collected.
Claim 2
Independent Claim
97 words
A method for non-invasively monitoring the concentration of an analyte in an individual's body comprising the steps of: (a) enhancing the permeability of a selected area of the individual's body surface to the analyte by means of applying ultrasound to said selected area for a time and at an intensity and a frequency effective to draw the analyte out of the body, wherein said ultrasound is modulated by means of a member selected from the group consisting of frequency modulation, amplitude modulation, phase modulation and combinations thereof; (b) collecting the analyte; and (c) quantitating the analyte collected.
Claim 3
Dependent Claim
33 words
The method of claim 1 wherein step (a) comprises modulating said ultrasound by means of a member selected from the group consisting of frequency modulation and a combination of frequency and amplitude modulation.
Claim 4
Dependent Claim
15 words
The method of claim 2 wherein step (a) comprises modulating said ultrasound by frequency modulation.
Claim 5
Dependent Claim
24 words
The method of claim 2 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 0.1 to 100 MHz.
Claim 6
Dependent Claim
24 words
The method of claim 4 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 3 to 30 MHz.
Claim 7
Dependent Claim
34 words
The method of claim 2 wherein step (a) comprises applying said frequency in a sweeping modulation from a lower frequency to a higher frequency for a time sufficient to withdraw analyte from the body.
Claim 8
Dependent Claim
15 words
The method of claim 1 wherein step (a) comprises modulating said ultrasound by amplitude modulation.
Claim 9
Dependent Claim
24 words
The method of claim 1 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 0.1 to 100 MHz.
Claim 10
Dependent Claim
18 words
The method of claim 1 wherein step (a) further comprises using a plurality of transducers for applying ultrasound.
Claim 11
Dependent Claim
24 words
The method of claim 1 wherein step (a) comprises applying said ultrasound for a time in the range of about 1 to 30 minutes.
Claim 12
Dependent Claim
29 words
The method of claim 1 additionally comprising measuring the amount of analyte collected over intervals of time and from that measurement determining the concentration of analyte in the body.
Claim 13
Dependent Claim
30 words
The method of claim 1 further comprising contacting the selected area of the individual's body with a chemical enhancer with the application of the ultrasound to further enhance analyte withdrawal.
Claim 14
Dependent Claim
33 words
The method of claim 12 wherein step (a) comprises modulating said ultrasound by means of a member selected from the group consisting of frequency modulation and a combination of frequency and amplitude modulation.
Claim 15
Dependent Claim
15 words
The method of claim 13 wherein step (a) comprises modulating said ultrasound by frequency modulation.
Claim 16
Dependent Claim
24 words
The method of claim 13 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 0.1 to 100 MHz.
Claim 17
Dependent Claim
24 words
The method of claim 15 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 3 to 30 MHz.
Claim 18
Dependent Claim
16 words
The method of claim 13 wherein step (a) comprises applying said frequency in a sweeping modulation.
Claim 19
Dependent Claim
66 words
The method of claim 13 wherein step (a) comprises modulating said ultrasound by frequency modulation, wherein the frequency is first modulated from a higher to a lower frequency for a time sufficient to enable the chemical enhancer to penetrate the body surface followed by modulating the frequency from a lower to a higher frequency for a time sufficient to withdraw analyte from within the body surface.
Claim 20
Dependent Claim
29 words
The method of claim 18 additionally comprising measuring the amount of analyte collected over intervals of time and from that measurement determining the concentration of analyte in the body.
Claim 21
Dependent Claim
18 words
The method of claim 19 further comprising collecting the analyte through binding of the analyte to a binder.
Claim 22
Dependent Claim
50 words
The method of claim 20 wherein step (c) comprises binding the analyte to said binder, wherein the binder is disposed on source and detection optical fibers and bound analyte attenuates an amount of light energy captured by the detection fiber, wherein quantity of attenuation is a measurement of analyte collected.
Claim 23
Dependent Claim
15 words
The method of claim 12 wherein step (a) comprises modulating said ultrasound by amplitude modulation.
Claim 24
Dependent Claim
24 words
The method of claim 12 wherein step (a) comprises applying said ultrasound at a frequency in the range of about 0.1 to 100 MHz.
Claim 25
Dependent Claim
18 words
The method of claim 12 wherein step (a) further comprises using a plurality of transducers for applying ultrasound.
Claim 26
Dependent Claim
24 words
The method of claim 12 wherein step (a) comprises applying said ultrasound for a time in the range of about 1 to 30 minutes.
Claim 27
Dependent Claim
20 words
The method of claim 12 wherein step (c) comprises binding the analyte to said binder, wherein the analyte is glucose.
Claim 28
Dependent Claim
20 words
The method of claim 26 wherein step (c) comprises quantitating the analyte collected by a colorimetric assay with glucose oxidase.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-10-16 | 1999-04-17 | 1999-10-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-10-16 | 2003-04-17 | 2003-10-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-10-16 | 2007-04-17 | 2007-10-17 | $7700.00 | Window Closed / Lapsed |